CUSIP 697947109COMPVLAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
139 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 892.4K | $93.41M | +70.0K | Added |
| 2 | Bvf Inc/Il | 879.0K | $92.01M | −282.2K | Reduced |
| 3 | Frazier Life Sciences Management, L.P. | 722.4K | $75.61M | 0 | Held |
| 4 | First Light Asset Management, LLC | 709.1K | $74.23M |
| +167.6K |
| Added |
| 5 | Vanguard Group Inc | 560.6K | $58.68M | +66.0K | Added |
| 6 | Blackrock, Inc. | 559.1K | $58.52M | +71.4K | Added |
| 7 | State Street Corp | 420.5K | $44.01M | +283.2K | Added |
| 8 | Summit Partners Public Asset Management, LLC | 389.4K | $40.76M | +354.5K | Added |
| 9 | Jennison Associates LLC | 387.5K | $40.56M | +280.6K | Added |
| 10 | Federated Hermes, Inc. | 368.0K | $38.52M | +29.0K | Added |
See every fund holding Palvella Therapeutics Inc Ne, with full quarter-over-quarter share changes.
Unlock all holders